Food and Drug Administration (FDA) has concurred that Clarins Expertise 3P (EP3) is a drug, not a cosmetic as advertised. The ruling comes after a complaint was filedby the National Toxic Encephalopathy Foundation In February, the NTEF notified the FDA that Clarins EP3 was making drug versus cosmetics claims and requested an investigation into these allegations. As previously stated: “We are now requesting that the FDA verify the claims made by Clarins, in vitro testing versus in vivo testing...